All stock reports

INDRAMEDCO evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-11T23:40:12.084463+00:00

Metrics

latest_annual_period
2026-03-31
revenue
14825100000.0
net_income
1836200000.0
operating_cash_flow
1893500000.0
free_cash_flow
1297000000.0
total_assets
9913600000.0
total_liabilities
2509900000.0
total_equity
7403700000.0
cash
2633000000.0
total_debt
368600000.0
revenue_growth
0.09300628151818091
earnings_growth
0.1405677371265297
net_margin
0.12385751192234791
roe
0.24801112957034996
debt_to_equity
0.04978591785188487
cash_conversion
1.0312057510075154
free_cash_flow_margin
0.08748676231526263
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-41ad41dc64c26a7812721db458fb95197c5f8581a382eb16b5467ac330890359
Policy
stock-decisions-v1
Evidence bundle hash
cdf0fa36de40a5b9f4825dd69f11f3e2bc92b8d193e9ef288086bfd839697502
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: ae2b32afc7a18325daace2feb408d2442c9b9a9ca386027654d6bb8bc4432d1f
  • daily-price: 26ac421270adf93dc70a314b1de3bb0fa86b8459b3596f096a0a81594575a8f4
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The cached closing price on 2026-10-01 was INR 338.60. The trailing 5-session price return was -8.61%. The trailing 20-session price return was -2.83%. The trailing 60-session price return was -7.59%. The trailing 250-session price return was -24.47%.

Risks

Average cached traded value over twenty sessions was INR 82,308,302. The closing price was -45.03% below its highest close in the available trailing year. The cached financial metric revenue growth is 0.09300628151818091. The cached financial metric debt to equity is 0.04978591785188487. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric net margin is 0.12385751192234791. The cached financial metric roe is 0.24801112957034996. The cached financial metric cash conversion is 1.0312057510075154. The cached financial metric free cash flow margin is 0.08748676231526263.

Cached observations and evidence limits